V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216365 | 20082324 | null | null | null | null | 2019-10-05 | null | null | null | HCX | 100053351 |
| 20216366 | 20082325 | 1.93 | 85 | null | 2019-01-28 | 2019-02-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100161097 |
| 20216367 | 20082326 | null | null | null | 2019-01-23 | 2019-01-25 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 101155579 |
| 20216368 | 20082327 | null | null | null | 2016-07-06 | 2016-07-06 | null | null | null | CAPECITABINE + IRINOTECAN | 101778801 |
| 20216369 | 20082328 | 1.56 | 70.8 | Palliative (P) | 2018-05-26 | 2018-06-01 | null | null | N | HCX | 100390701 |
| 20216370 | 20082329 | 1.66 | 50 | Palliative (P) | null | 2019-05-16 | null | null | N | CISPLATIN + ETOPOSIDE | 101551273 |
| 20216371 | 20082330 | 1.8 | 77.6 | Palliative (P) | 2021-03-05 | 2021-03-29 | null | null | null | HCX | 101401598 |
| 20216373 | 20082332 | null | null | null | null | 2016-02-17 | null | null | null | CAPECITABINE + IRINOTECAN | 100298894 |
| 20216374 | 20082333 | null | 62.5 | Curative (C) | 2018-02-11 | 2018-02-14 | CAPECITABINE + MITOMYCIN + RT | N | N | CAPECITABINE + MITOMYCIN + RT | 100658648 |
| 20216375 | 20082334 | 1.53 | 65.5 | Palliative (P) | 2016-12-01 | 2016-12-23 | HCX (Cape + Cisp + Tras) - Load | N | N | HCX | 101036477 |
| 20216377 | 20082336 | 1.7 | 107 | Neo-adjuvant (N) | 2019-04-18 | 2019-04-23 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100861201 |
| 20216378 | 20082337 | 1.68 | 59 | null | null | 2020-03-25 | null | null | Y | CETUXIMAB + IRINOTECAN + MDG | 101308670 |
| 20216382 | 20082338 | 2.08 | 80.8 | Curative (C) | 2018-05-03 | 2018-05-21 | Cisplatin + Etoposide po&iv 3 day | 02 | N | CISPLATIN + ETOPOSIDE | 101532643 |
| 20216383 | 20082339 | null | null | null | null | 2018-06-08 | Capecitabine (14 day) + Irinotecan | N | null | CAPECITABINE + IRINOTECAN | 101319657 |
| 20216384 | 20082340 | 1.79 | 106 | Palliative (P) | 2018-07-16 | 2018-07-24 | ECarboX | null | N | HCX | 100758441 |
| 20216385 | 20082341 | 1.7 | 208 | null | 2017-07-01 | 2017-07-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 101462376 |
| 20216386 | 20082342 | 1.91 | 71.9 | Palliative (P) | null | 2016-07-27 | null | null | N | HCX | 101830826 |
| 20216389 | 20082344 | 1.83 | null | Palliative (P) | null | 2018-05-18 | Cisplatin + Etoposide (3 day) | N | N | CISPLATIN + ETOPOSIDE | 101552828 |
| 20216390 | 20082345 | 1.68 | 71.9 | Curative (C) | null | 2018-04-08 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 101138102 |
| 20216391 | 20082346 | 1.84 | 83 | Palliative (P) | 2020-11-10 | 2020-11-18 | null | null | N | CISPLATIN + ETOPOSIDE | 101708636 |
| 20216394 | 20082348 | null | null | null | 2017-10-24 | 2017-10-24 | CISPLATIN + ETOPOSIDE | 02 | null | CISPLATIN + ETOPOSIDE | 100348850 |
| 20216395 | 20082349 | 1.49 | 59 | null | null | 2019-01-26 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101416159 |
| 20216397 | 20082350 | 1.58 | 68.8 | Curative (C) | 2018-06-19 | 2018-06-22 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101397437 |
| 20216398 | 20082351 | 1.77 | 81.95 | Palliative (P) | null | 2019-08-29 | null | null | N | CAPECITABINE + IRINOTECAN | 100901447 |
| 20216399 | 20082352 | 167.5 | 74.3 | null | 2018-04-21 | 2018-05-01 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 100393419 |
| 20216400 | 20082353 | 1.58 | 95.7 | Palliative (P) | 2017-05-24 | 2017-05-31 | null | null | N | CAPECITABINE + IRINOTECAN | 101633675 |
| 20216401 | 20082354 | 1.68 | 75 | null | null | 2020-06-15 | null | null | Y | LENVATINIB | 100335388 |
| 20216402 | 20082355 | 1.86 | 57 | Disease modification (D) | null | 2016-09-27 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101184001 |
| 20216403 | 20082356 | 1.77 | 117.8 | null | 2017-08-20 | 2017-08-31 | LENVATINIB | 02 | null | LENVATINIB | 101754870 |
| 20216405 | 20082358 | null | null | null | 2019-08-05 | 2019-08-05 | LENVATINIB | 02 | null | LENVATINIB | 101784492 |
| 20216406 | 20082359 | null | null | null | 2018-06-26 | 2018-07-01 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100669463 |
| 20216407 | 20082360 | 1.82 | 85.6 | Palliative (P) | 2018-10-09 | 2018-10-14 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100566975 |
| 20216408 | 20082361 | 1.61 | 83.15 | Curative (C) | null | 2016-08-01 | null | null | N | CISPLATIN + ETOPOSIDE | 101809100 |
| 20216409 | 20082362 | 1.74 | 57 | Palliative (P) | 2017-07-25 | 2017-07-29 | Cape+Cisplatin+Trastuzumab Main | 02 | N | HCX | 100032003 |
| 20216410 | 20082363 | 1.76 | 72.6 | Curative (C) | null | 2017-08-10 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101170759 |
| 20216411 | 20082364 | 1.78 | 70.1 | Palliative (P) | null | 2019-10-15 | null | null | Y | CAPECITABINE + IRINOTECAN | 100164525 |
| 20216412 | 20082365 | 1.77 | 63.65 | Palliative (P) | 2017-10-26 | 2017-10-26 | CISPLATIN + ETOPOSIDE | 02 | N | CISPLATIN + ETOPOSIDE | 100414168 |
| 20216413 | 20082366 | 1.64 | 84 | Palliative (P) | 2018-06-12 | 2018-07-02 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101290026 |
| 20216414 | 20082367 | null | null | null | null | 2017-03-08 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100917725 |
| 20216415 | 20082368 | null | null | null | 2019-07-03 | 2019-07-05 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100934331 |
| 20216417 | 20082370 | 1.87 | 79 | Neo-adjuvant (N) | 2016-05-17 | 2016-06-04 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100464567 |
| 20216418 | 20082371 | 1.75 | 67.5 | Palliative (P) | 2017-09-08 | 2017-09-18 | LENVATINIB | 02 | N | LENVATINIB | 101382919 |
| 20216419 | 20082372 | null | null | null | 2019-12-25 | 2019-12-31 | CISPLATIN + ETOPOSIDE | N | null | CISPLATIN + ETOPOSIDE | 100871244 |
| 20216420 | 20082373 | 1.61 | 71 | Palliative (P) | null | 2018-06-19 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100843875 |
| 20216421 | 20082374 | 1.86 | 70.7 | Palliative (P) | null | 2018-10-25 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | HCX | 101309431 |
| 20216423 | 20082376 | 1.74 | 70 | Curative (C) | null | 2018-10-19 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 100430790 |
| 20216424 | 20082377 | 1.68 | 71.8 | Palliative (P) | null | 2016-12-26 | null | null | N | CISPLATIN + ETOPOSIDE | 101711579 |
| 20216425 | 20082378 | null | null | null | null | 2019-07-22 | null | null | null | CAPECITABINE + IRINOTECAN | 100923965 |
| 20216426 | 20082379 | 1.76 | 91.6 | Palliative (P) | 2016-07-06 | 2016-07-19 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100324483 |
| 20216428 | 20082380 | null | null | null | null | 2019-06-01 | null | null | null | CISPLATIN + ETOPOSIDE | 101114877 |